Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10756781rdf:typepubmed:Citationlld:pubmed
pubmed-article:10756781lifeskim:mentionsumls-concept:C0028754lld:lifeskim
pubmed-article:10756781lifeskim:mentionsumls-concept:C0040223lld:lifeskim
pubmed-article:10756781lifeskim:mentionsumls-concept:C0015219lld:lifeskim
pubmed-article:10756781pubmed:issue3-4lld:pubmed
pubmed-article:10756781pubmed:dateCreated2000-5-19lld:pubmed
pubmed-article:10756781pubmed:abstractTextThere is a steady-state metabolism of adipose tissue ("adipose state") with a "metabolic signal" significance. It consists of: seric levels of glucose, insulin, free fatty acids. We studied 45 cases with uncomplicated obesity and we correlated seric level of insulin, basal and reactive, with DAM (mean adipocyte diameter), insulin receptor activity and obesity evolution length (age of obesity). Level of insulin has high influence on insulin receptor function (p < 0.01). Reactive insulin level are higher with obesity age (p < 0.0001). Hyperinsulinemia is a constant, continuous and early reference point of obesity.lld:pubmed
pubmed-article:10756781pubmed:languagerumlld:pubmed
pubmed-article:10756781pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10756781pubmed:citationSubsetIMlld:pubmed
pubmed-article:10756781pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10756781pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10756781pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10756781pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10756781pubmed:statusMEDLINElld:pubmed
pubmed-article:10756781pubmed:issn0048-7848lld:pubmed
pubmed-article:10756781pubmed:authorpubmed-author:GeorgescoAAlld:pubmed
pubmed-article:10756781pubmed:authorpubmed-author:RusuVVlld:pubmed
pubmed-article:10756781pubmed:authorpubmed-author:BurcoveanuCClld:pubmed
pubmed-article:10756781pubmed:authorpubmed-author:PetrovanuRRlld:pubmed
pubmed-article:10756781pubmed:authorpubmed-author:ComanAAlld:pubmed
pubmed-article:10756781pubmed:issnTypePrintlld:pubmed
pubmed-article:10756781pubmed:volume101lld:pubmed
pubmed-article:10756781pubmed:ownerNLMlld:pubmed
pubmed-article:10756781pubmed:authorsCompleteYlld:pubmed
pubmed-article:10756781pubmed:pagination116-9lld:pubmed
pubmed-article:10756781pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:10756781pubmed:meshHeadingpubmed-meshheading:10756781...lld:pubmed
pubmed-article:10756781pubmed:meshHeadingpubmed-meshheading:10756781...lld:pubmed
pubmed-article:10756781pubmed:meshHeadingpubmed-meshheading:10756781...lld:pubmed
pubmed-article:10756781pubmed:meshHeadingpubmed-meshheading:10756781...lld:pubmed
pubmed-article:10756781pubmed:meshHeadingpubmed-meshheading:10756781...lld:pubmed
pubmed-article:10756781pubmed:meshHeadingpubmed-meshheading:10756781...lld:pubmed
pubmed-article:10756781pubmed:meshHeadingpubmed-meshheading:10756781...lld:pubmed
pubmed-article:10756781pubmed:meshHeadingpubmed-meshheading:10756781...lld:pubmed
pubmed-article:10756781pubmed:meshHeadingpubmed-meshheading:10756781...lld:pubmed
pubmed-article:10756781pubmed:meshHeadingpubmed-meshheading:10756781...lld:pubmed
pubmed-article:10756781pubmed:meshHeadingpubmed-meshheading:10756781...lld:pubmed
pubmed-article:10756781pubmed:meshHeadingpubmed-meshheading:10756781...lld:pubmed
pubmed-article:10756781pubmed:meshHeadingpubmed-meshheading:10756781...lld:pubmed
pubmed-article:10756781pubmed:articleTitle[Insulinemia and its evolution over time in obesity].lld:pubmed
pubmed-article:10756781pubmed:affiliationMedicin? Intern? de ambulator, Facultatea de Medicin?, Universitatea de Medicin? ?i Farmacie Gr. T. Popa, Ia?i.lld:pubmed
pubmed-article:10756781pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10756781pubmed:publicationTypeEnglish Abstractlld:pubmed